• Treatment variation impacts survival in early-onset metastatic CRC

    A retrospective analysis of patients diagnosed with stage IV CRC between 2004-2022 found that treatment patterns and outcomes varied by age, with patients under 50 showing different utilization of chemotherapy, immunotherapy, and metastasis resection compared to older age groups. (J Surg Oncol)